NEJM:淋巴结核治疗过程中的反常反应-病例报道

2020-10-29 MedSci原创 MedSci原创

在显微镜下观察到了抗酸杆菌,并且培养到了结核分枝杆菌,其对一线抗结核治疗药物敏感。人类免疫缺陷病毒的检测结果为阴性。该患者被诊断为分枝杆菌性颈淋巴结炎。

患者为一名66岁的男子,因颈部右下侧有一个逐渐增大的肿块1个月而到门诊就诊(如图A所示),其他感觉良好。

他的体温为37.0°C,似乎没有恶病质。经检查,颈部肿块柔软且无压痛,最大尺寸为5.5cm。胸部X光片未见肺部病变。对颈部和胸部进行计算机断层扫描的结果发现多发淋巴结肿大,周围增强,从颈部右下侧延伸至纵隔。进行颈部肿物的细针抽吸活检。在显微镜下观察到了抗酸杆菌,并且培养到了结核分枝杆菌,其对一线抗结核治疗药物敏感。人类免疫缺陷病毒的检测结果为阴性。该患者被诊断为分枝杆菌性颈淋巴结炎。

该患者开始采用利福平、异烟肼、吡嗪酰胺和乙胺丁醇治疗。在治疗的前3个月(如图B所示,治疗的第84天),颈部肿块出现反常反应,进行引流,但在伤口护理过程中,颈部肿块在5个月内逐渐消退(如图C所示,治疗的第156天)。

该患者完成了9个月的治疗,在治疗结束后3个月的随访中,他恢复了健康,没有出现疾病复发。

原始出处:

Kuan-Chung Ting,et al.Paradoxical Reaction in the Treatment of Scrofula.N Engl J Med.2020;https://www.nejm.org/doi/full/10.1056/NEJMicm2001912

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-09-08 keke123

    确诊了淋巴结结核,仍然需要抗结核治疗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-30 sodoo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 小光皮球

    好用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 182201837cm

    好用

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1015658, encodeId=a07310156583f, content=确诊了淋巴结结核,仍然需要抗结核治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=806488397, createdName=keke123, createdTime=Wed Sep 08 12:13:40 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254382, encodeId=bb2d125438214, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293109, encodeId=13dc129310905, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Oct 30 23:02:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035472, encodeId=d5bb10354e2b3, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 29 11:02:51 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895366, encodeId=696d89536614, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae35430026, createdName=小光皮球, createdTime=Thu Oct 29 10:41:31 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895264, encodeId=cef789526444, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7d62153496, createdName=182201837cm, createdTime=Thu Oct 29 09:16:39 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895249, encodeId=c486895249d8, content=淋巴结核原来也是抗结核药物治疗,学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/f392697b67704065936a7d71c903356a/fc8145bc7e334842b4af1845278faea4.jpg, createdBy=60255339175, createdName=ms3000002005028696, createdTime=Thu Oct 29 08:06:31 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 ms3000002005028696

    淋巴结核原来也是抗结核药物治疗,学到了

    0

相关资讯

Pharmaceutics:壳聚糖水凝胶掺杂PEG-PLA纳米颗粒来局部递送miRNA-146a和治疗变应性鼻炎

最近,有研究人员制备了一种递送miRNA-146的二元制剂,并通过调查其在过敏性鼻炎中的药效作用,评估了该核酸鼻腔递送系统。

Nat Commun :重大进展!中山大学蔡俊超/吴珏珩发现肺腺癌新的潜在治疗靶标

尽管AKT过度活化在肿瘤进展中很重要,但是各种AKT抑制剂的临床试验结果仍然不是最佳的,这表明需要进一步了解AKT驱动的肿瘤转移。

Science Advances : 重大进展!薛雪/师冰洋​/郑蒙开发新的递送方法,将siRNA递送至大脑治疗阿尔茨海默病

有毒聚集的淀粉样β积累是阿尔茨海默病(AD)的关键致病事件,它是由淀粉样前体蛋白(APP)通过BACE1(β位APP裂解酶1)和γ分泌酶裂解而产生的。

PNAS:细胞膜纳米囊泡,缓解新冠肺炎的新疗法

由新冠病毒SARS-CoV-2引起的COVID-19新冠肺炎大流行,给人类的医疗、经济、生活带来了巨大的负面影响。如何快速应对正在发生的COVID-19新冠肺炎以及潜在的新发流行疾病?

Science:发现一种罕见的痴呆症基因,为治疗阿尔兹海默症等疾病开辟新道路

阿尔茨海默症(Alzheimer's disease, AD),俗称“老年痴呆症”,是一类主要发生于老年人且以进行性认知功能障碍和行为损害为特征的中枢神经系统退行性病变。

Science Advances :重大进展!延边大学等多单位合作,发现结肠炎的新干预策略

溃疡性结肠炎和克罗恩氏病是人类炎性肠病(IBD)的最常见形式。尽管确切的病因仍然未知,但是IBD的发展被广泛认为是遗传和环境因素共同决定的结果。